NT5C2 and pancreatic adenocarcinoma: In patients with PAAD, overexpression of NT5C2 mRNA was associated with poor OS; overexpression of NT5DC2/4 mRNA was significantly associated with poor RFS; and overexpression of NT5DC3 mRNA was correlated with better RFS.